SNG-2004

N/A

Report date: 2024/12/02 13:50:01

Base Information

Drug NameSNG-2004
Drug Alias NameSNG-2004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Shenogen Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Shenogen Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A